trial · primary record
Poziotinib
NSCLC
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 268 |
| Primary completion | 2028-12-25 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT05378763 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:37.737Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05378763
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.